Literature DB >> 7070561

Flucloxacillin-associated liver damage.

S Lobatto, B A Dijkmans, H Mattie, J P Van Hooff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7070561

Source DB:  PubMed          Journal:  Neth J Med        ISSN： 0300-2977            Impact factor:   1.422


× No keyword cloud information.
  5 in total

1.  Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database.

Authors:  Stefan Russmann; James A Kaye; Susan S Jick; Hershel Jick
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

2.  Granulomatous hepatitis due to combination of amoxicillin and clavulanic acid.

Authors:  C Silvain; E Fort; P Levillain; J Labat-Labourdette; M Beauchant
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

Review 3.  Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?

Authors:  B M Devereaux; D H Crawford; P Purcell; L W Powell; H P Roeser
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 4.  Nafcillin-associated hepatotoxicity. Report of a case and review of the literature.

Authors:  M E Presti; C G Janney; B A Neuschwander-Tetri
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

5.  Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin)

Authors:  B H Stricker; J W Van den Broek; J Keuning; W Eberhardt; H G Houben; M Johnson; A P Blok
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.